Significados de biliary tract en inglés

Liver and biliary tract diseases are common causes of morbidity and mortality worldwide.

We evaluated the combination of 3-AP plus gemcitabine in advanced biliary tract adenocarcinoma.

Ultrasonography of the abdomen revealed no abnormality in the liver or biliary tract.

Conclusion: Tumor marker decline was associated with improved survival in biliary tract cancer.

The only curative treatment in biliary tract cancer is surgical treatment.

Findings at ERCP excluded biliary tract involvement in 11 cases.

Bile duct cysts are rare abnormalities of the biliary tract.

Twenty-nine patients had pancreatic cancer whereas 21 patients had biliary tract or ampullary cancers.

Routine testing for BRAFV600E mutations should be considered in patients with biliary tract cancer.

Epidemiology data from India suggest that biliary tract carcinomas occur primarily in the older population.

We analyze the biliary tract reconstruction after liver transplantation, its risk factors and the management.

The use of MRCP is becoming more frequent in diagnostic imaging of the biliary tract.

Histology revealed an adenocarcinoma of the biliary tract with expression of epithelial growth factor receptor.

Conclusion: Gemcitabine and S-1 combination chemotherapy is effective and safe in patients with advanced biliary tract cancer.

Especially patients with noncystic dilatation and without dilatation of the biliary tract are at risk of gallbladder carcinoma.

Unrecognized biliary tract obstruction due to choledochal cysts or biliary atresia can result in significant morbidity and mortality.